Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Results demonstrated that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo. Critically, the peptide produced no clinically significant alterations in IGF-1 levels, no glucose intolerance or insulin resistance, and no anti-AOD9604 antibodies in any participant
How is the AOD-9604 Vial prepared for laboratory research
Most patients follow a titration schedule over several weeks before reaching a therapeutic dose
Can I drink alcohol while preparing for or using AOD-9604
We DO NOT treat acute illness
US$ 29.41
US$ 29.41
US$ 21.85
US$ 29.41
